Innate Pharma
IPHA
1,64 €
Share price
0.55%
Change (1 day)
-31.38%
Change (1 year)
Categories
EPS for Innate Pharma (IPHA)
EPS in 2022: -0,70 €
According to Innate Pharma 's latest financial reports the company's current EPS (TTM) is -0,70 €. In 2022 the company made an earnings per share (EPS) of -0,70 € a decrease over its 2021 EPS that were of -0,67 €.
EPS history for Innate Pharma from 2005 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 | -0,70 € | 4.6% |
| 2021 | -0,67 € | -24.98% |
| 2020 | -0,89 € | 186.89% |
| 2019 | -0,31 € | -707.12% |
| 2018 | 0,05135 € | -105.35% |
| 2017 | -0,96 € | -541.28% |
| 2016 | 0,22 € | -270.34% |
| 2015 | -0,13 € | -70.03% |
| 2014 | -0,43 € | 390.66% |
| 2013 | -0,08679 € | -8.65% |
| 2012 | -0,09501 € | -57.03% |
| 2011 | -0,22 € | -48.58% |
| 2010 | -0,43 € | -40.32% |
| 2009 | -0,72 € | 24.76% |
| 2008 | -0,58 € | 22.34% |
| 2007 | -0,47 € | 16.95% |
| 2006 | -0,40 € | -7.23% |
| 2005 | -0,43 € |